poloxalene has been researched along with Central Nervous System Toxoplasmosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, FG; Slifer, T | 1 |
1 other study(ies) available for poloxalene and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
Topics: Animals; Anti-Infective Agents; Cytokines; Drug Synergism; Encephalitis; Female; Lymphocyte Activation; Mice; Mice, Inbred CBA; Poloxalene; Spleen; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral | 1995 |